Effects of radioiodine treatment for differentiated thyroid cancer on testis function
- PMID: 25138547
- DOI: 10.1111/cen.12514
Effects of radioiodine treatment for differentiated thyroid cancer on testis function
Abstract
Objective: To evaluate the effects of radioactive iodine (RAI) treatment for differentiated thyroid cancer (DTC) on testis function.
Design: A prospective longitudinal single-centre study was performed. A comprehensive andrological evaluation including hormonal assessment, semen analysis and scrotal ultrasound was undertaken in male patients undergoing RAI treatment for DTC.
Methods: Hormonal assessment of FSH, LH, testosterone (T), sperm concentration and motility and testis volume were determined in 20 patients in basal conditions, 6 and 12 months after RAI. Results were analysed in the whole group of patients and then separately in those who received one single ablative treatment ('Single' group, n = 10) and those who received multiple treatments ('Multiple' group, n = 10).
Results: In basal conditions, 3 of 20 (15%) patients had a reduced sperm count and belonged to the 'Multiple' group. After RAI, an increase of FSH (8·8 ± 1·2 UI/l vs 5·2 ± 1·2, P < 0·005) and a decrease in sperm concentration (28·8 ± 7·7 millions/ml vs 54·5 ± 7·1, P < 0·005) and testis volume (15·2 ± 3·1 vs 13·7 ± 0·8 ml, P < 0·005) occurred at 6 months in the whole group. One year after RAI, seven patients had oligozoospermia (five from the 'Multiple' group and two from the 'Single' group). Permanent impairment of one or more testis function parameters was observed in patients who underwent multiple RAI treatments: 50% for sperm count, 40% for FSH levels and testis volume and, respectively, in 20 and 10% of those who received one single RAI treatment.
Conclusions: The single ablative RAI treatment in cancer patients is better tolerated respect multiple RAI treatments regard testis function. Multiple treatments for recurrent or metastatic disease may cause a permanent impairment of one or more parameters related to the reproductive potential of male patients.
© 2014 John Wiley & Sons Ltd.
Similar articles
-
Impact on testicular function of a single ablative activity of 3.7 GBq radioactive iodine for differentiated thyroid carcinoma.Hum Reprod. 2018 Aug 1;33(8):1408-1416. doi: 10.1093/humrep/dey222. Hum Reprod. 2018. PMID: 29912343
-
Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma.Clin Nucl Med. 2018 Jul;43(7):482-485. doi: 10.1097/RLU.0000000000002078. Clin Nucl Med. 2018. PMID: 29688947
-
Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine.J Nucl Med. 1994 Sep;35(9):1418-22. J Nucl Med. 1994. PMID: 8071685
-
Well-differentiated thyroid carcinoma: the role of post-operative radioactive iodine administration.J Surg Oncol. 2013 May;107(6):665-72. doi: 10.1002/jso.23295. Epub 2012 Nov 28. J Surg Oncol. 2013. PMID: 23192391 Review.
-
A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors.Clin Endocrinol (Oxf). 2008 Sep;69(3):479-90. doi: 10.1111/j.1365-2265.2008.03222.x. Epub 2008 Feb 13. Clin Endocrinol (Oxf). 2008. PMID: 18284643 Review.
Cited by
-
The effect of radioactive iodine treatment for differentiated thyroid cancer on male gonadal function: a meta-analysis.Endocr Connect. 2023 Nov 9;12(12):e230299. doi: 10.1530/EC-23-0299. Print 2023 Dec 1. Endocr Connect. 2023. PMID: 37855387 Free PMC article.
-
Effects of radioiodine therapy on fertility indicators among men with differentiated thyroid cancer: A cohort study.Int J Reprod Biomed. 2023 May 12;21(5):387-394. doi: 10.18502/ijrm.v21i5.13472. eCollection 2023 May. Int J Reprod Biomed. 2023. PMID: 37362091 Free PMC article.
-
2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma.Eur Thyroid J. 2022 Nov 29;11(6):e220146. doi: 10.1530/ETJ-22-0146. Print 2022 Dec 1. Eur Thyroid J. 2022. PMID: 36228315 Free PMC article.
-
2021 European Thyroid Association Guideline on Thyroid Disorders prior to and during Assisted Reproduction.Eur Thyroid J. 2021 Feb;9(6):281-295. doi: 10.1159/000512790. Epub 2021 Jan 21. Eur Thyroid J. 2021. PMID: 33718252 Free PMC article.
-
Less than 2% of the Low- and Intermediate-Risk Differentiated Thyroid Cancers Show Distant Metastases at Post-Ablation Whole-Body Scan.Eur Thyroid J. 2019 Apr;8(2):90-95. doi: 10.1159/000494290. Epub 2018 Dec 13. Eur Thyroid J. 2019. PMID: 31192148 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical